Articles tagged with "biosimilar"

Canada Approves Erelzi for PsA; Plus FDA Moves to Increase Access to Naloxone

February 4, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Rituximab Biosimilar; Plus New Safety Data for Filgotinib in RA Patients

January 7, 2019 • By Michele B. Kaufman, PharmD, BCGP

EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray

August 8, 2018 • By Michele B. Kaufman, PharmD, BCGP

Etanercept Biosimilar Is Effective, Well-Tolerated for Rheumatoid Arthritis

February 16, 2018 • By David Douglas

Biosimilars: Still Waiting for Promise to Materialize

January 17, 2018 • By Larry Beresford

Biosimilar SB2 May Work as Well as Infliximab for Rheumatoid Arthritis

January 8, 2018 • By Lara C. Pullen, PhD

Pfizer’s Second Biosimilar of J&J’s Remicade Wins U.S. FDA Approval

December 14, 2017 • By Tamara Mathias

Biosimilars Great Debate: To Switch or Not?

November 17, 2017 • By Susan Bernstein

Rheumatology Drug Updates: Biosiomilar to Adalimumab Receives FDA Approval; plus Updates on Baricitinib, Tofacitinib, Bimekizumab

October 17, 2017 • By Mary Beth Nierengarten

Report on EU’s Experience with Biosimilar Drugs Released: Will U.S. Experience Be Similar?

October 17, 2017 • By Vanessa Caceres